Keyphrases
Adenosine Diphosphate Ribose
75%
Area under the Receiver Operating Characteristic Curve
25%
Biodistribution Studies
25%
Clinical Application
25%
Clinical Trial Evaluation
25%
Effective Dose
25%
First-in-human Study
100%
Fluorine-18
25%
Healthy Volunteers
25%
Human Subjects
25%
In Cancer
100%
Inhibitory Activity
25%
Iniparib
100%
Institutional Review Board
25%
Liver Cancer
25%
Median Difference
50%
Mouse Organs
25%
Olaparib
100%
Pancreas
25%
Pancreatic Adenocarcinoma
25%
Poly(adenosine diphosphate-ribose) Polymerase inhibitor
25%
Poly(ADP-ribose) Polymerase
100%
Polyadenosine
75%
Polymerase
75%
Positron Emission Tomography
100%
Preclinical Assessment
100%
Radiation Dosimetry
50%
Spine
25%
Spleen
25%
Translational Studies
25%
Treatment Group
25%
Tumor
25%
Wilcoxon Signed-rank Test
25%
Medicine and Dentistry
Biodistribution
12%
Clinical Trial
12%
Dosimetry
25%
Fluorine-18
100%
Human Study
100%
Human Subject
12%
Iniparib
50%
Liver Cancer
12%
Malignant Neoplasm
100%
Mouse Study
12%
Neoplasm
12%
Olaparib
50%
Pancreas Adenocarcinoma
12%
Poly ADP Ribose Polymerase
100%
Positron Emission Tomography
100%
Treatment Group
12%
Volunteer
12%
Wilcoxon Signed Ranks Test
12%
Pharmacology, Toxicology and Pharmaceutical Science
Biodistribution
12%
Clinical Trial
12%
Dosimetry
25%
Fluorine 18
100%
Homo sapiens
12%
Human Study
100%
Iniparib
50%
Liver Cancer
12%
Malignant Neoplasm
100%
Neoplasm
12%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase
100%
Normal Human
12%
Olaparib
50%
Pancreas Adenocarcinoma
12%
Treatment Group
12%